Scribe Therapeutics' shares are set to begin trading on Nasdaq, following an analysis of IPO trends by HSBC.

The entities involved

• Scribe Therapeutics →

  genetic medicine therapeutics company from Alameda, California

  Nothing else this week.

• Nasdaq →

  American fully electronic stock exchange

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28
• HSBC →

  British multinational bank

  • HSBC utilized its Orion platform for a bond issuance, which was reported by Reuters and involves S&P sovereign ratings for Hong Kong.Mon 06:51
  • Alphabet filed a disclosure with the SEC and HSBC partnered with Google Cloud for AI.Mon 05:51

Related events

• IPO trading is expected to commence on Nasdaq.Jun 25
• Holtec Nuclear Corporation plans to seek an Initial Public Offering (IPO) in the US market by listing its shares on Nasdaq.Jul 11
• Arrive AI traded on the Nasdaq stock exchange, with its performance covered by financial blog MarketBeat.Aug 30
• BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.Jul 31
• SciSparc conducted an IPO on NASDAQ, is headquartered in Switzerland, and its information is reported via MarketBeat.Aug 31